ipilimumab,nivolumab
bms
['nivo', 'check,mate,914', 'rcc,(-irccs),(-srcc),(-urcc)', 'ipilimumab', 'nivolumab', 'checkmate914']
adjuvant nivolumab + ipilimumab vs pbo for localized #rcc at high risk of relapse after nephrectomy: results from the randomized, phase 3 #checkmate914 trial. presented by . #esmo22 written coverage by &gt; 
Largest global online community of #urological medical professionals & patients. #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology